Tempus gets FDA clearance for pulmonary hypertension AI

RegulatoryapprovedPositive

AI Analysis

Summary

Tempus received FDA clearance for an AI solution designed for pulmonary hypertension, representing a regulatory approval for the company's diagnostic technology.

Outcome Details

FDA clearance for AI solution for pulmonary hypertension

Importance:7/10

Sentiment:

0.80

FDA clearanceAIpulmonary hypertensionregulatory approval

Related Companies

$TEM

Read the original article

Published by Seeking Alpha Healthcare on August 24, 2026 1:06 PM

Read Original